MovDisordV3, Main, Exploration, bibRecord, 006125

Segmental ballistic movement overflow myoclonus: A clinical, electromyographic, and pharmacologic evaluation

Identifieur interne : 006125 ( Main/Exploration ); précédent : 006124; suivant : 006126

Segmental ballistic movement overflow myoclonus: A clinical, electromyographic, and pharmacologic evaluation

Auteurs : J. Stübgen [Afrique du Sud] ; Lotz [Afrique du Sud]

Source :

Movement Disorders [ 0885-3185 ] ; 1991.

RBID : ISTEX:FD82B6B0535553A995DE84CEDF512FDC6E98A34F

Descripteurs français

Pascal (Inist)
- Adulte jeune, Efficacité traitement, Electrodiagnostic, Electromyographie, Etude cas, Exploration, Hémiballisme, Myoclonie, Radiodiagnostic, Système nerveux central, Tomodensitométrie.

English descriptors

KwdEn :
- Adult, Ballistic movement overflow myoclonus, Biperiden (therapeutic use), Case study, Central nervous system, Cholinergic Fibers (drug effects), Cholinergic Fibers (physiology), Cholinergic disturbance, Computerized axial tomography, Drug response, Electrodiagnosis, Electromyography, Electromyography (drug effects), Exploration, Hemibalismus, Humans, Infusions, Intravenous, Male, Muscle Contraction (drug effects), Muscle Contraction (physiology), Muscles (innervation), Myoclonus, Myoclonus (drug therapy), Myoclonus (physiopathology), Neurologic Examination, Radiodiagnosis, Receptors, Cholinergic (drug effects), Receptors, Cholinergic (physiology), Treatment efficiency, Young adult.
MESH :
- chemical , drug effects : Receptors, Cholinergic.
- chemical , physiology : Receptors, Cholinergic.
- chemical , therapeutic use : Biperiden.
- drug effects : Cholinergic Fibers, Electromyography, Muscle Contraction.
- drug therapy : Myoclonus.
- innervation : Muscles.
- physiology : Cholinergic Fibers, Muscle Contraction.
- physiopathology : Myoclonus.
- Adult, Humans, Infusions, Intravenous, Male, Neurologic Examination.

Abstract

A 27‐year‐old man presented with a sporadic, nonprogressive, right‐sided, segmental movement disorder that had started at the age of 2 years. Ballistic movement overflow myoclonus was diagnosed clinically and by surface electromyography. Special investigations did not detect anything except atrophy of the left temporal lobe on CT scan. The movement intensity was attenuated by alcohol but was minimally affected by high doses of oral propranolol (320 mg daily), clonazepam (36 mg daily), or trihexyphenidyl (32 mg daily). High‐dose intravenous biperidine (10 mg) resulted in dramatic improvement, but with unacceptable side effects. The possible role of a cholinergic disturbance in generating myoclonus is discussed.

Url:

https://api.istex.fr/document/FD82B6B0535553A995DE84CEDF512FDC6E98A34F/fulltext/pdf

DOI: 10.1002/mds.870060415

Affiliations:

Afrique du Sud

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Segmental ballistic movement overflow myoclonus: A clinical, electromyographic, and pharmacologic evaluation</title>
<author><name sortKey="Stubgen, J" sort="Stubgen, J" uniqKey="Stubgen J" first="J." last="Stübgen">J. Stübgen</name>
</author>
<author><name sortKey="Lotz" sort="Lotz" uniqKey="Lotz" last="Lotz">Lotz</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:FD82B6B0535553A995DE84CEDF512FDC6E98A34F</idno>
<date when="1991" year="1991">1991</date>
<idno type="doi">10.1002/mds.870060415</idno>
<idno type="url">https://api.istex.fr/document/FD82B6B0535553A995DE84CEDF512FDC6E98A34F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003373</idno>
<idno type="wicri:Area/Istex/Curation">003373</idno>
<idno type="wicri:Area/Istex/Checkpoint">004268</idno>
<idno type="wicri:doubleKey">0885-3185:1991:Stubgen J:segmental:ballistic:movement</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:1758455</idno>
<idno type="wicri:Area/PubMed/Corpus">004E41</idno>
<idno type="wicri:Area/PubMed/Curation">004E41</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004D93</idno>
<idno type="wicri:Area/Ncbi/Merge">001D33</idno>
<idno type="wicri:Area/Ncbi/Curation">001D33</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001D33</idno>
<idno type="wicri:doubleKey">0885-3185:1991:Stubgen J:segmental:ballistic:movement</idno>
<idno type="wicri:Area/Main/Merge">009429</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:93-0155512</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003782</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003042</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">003853</idno>
<idno type="wicri:doubleKey">0885-3185:1991:Stubgen J:segmental:ballistic:movement</idno>
<idno type="wicri:Area/Main/Merge">009525</idno>
<idno type="wicri:Area/Main/Curation">006125</idno>
<idno type="wicri:Area/Main/Exploration">006125</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Segmental ballistic movement overflow myoclonus: A clinical, electromyographic, and pharmacologic evaluation</title>
<author><name sortKey="Stubgen, J" sort="Stubgen, J" uniqKey="Stubgen J" first="J." last="Stübgen">J. Stübgen</name>
<affiliation wicri:level="1"><country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Department of Neurology, H. F. Verwoerd Hospital, University of Pretoria</wicri:regionArea>
<wicri:noRegion>University of Pretoria</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lotz" sort="Lotz" uniqKey="Lotz" last="Lotz">Lotz</name>
<affiliation wicri:level="1"><country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Department of Neurology, H. F. Verwoerd Hospital, University of Pretoria</wicri:regionArea>
<wicri:noRegion>University of Pretoria</wicri:noRegion>
</affiliation>
<affiliation><wicri:noCountry code="subField">0001</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1991">1991</date>
<biblScope unit="vol">6</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="350">350</biblScope>
<biblScope unit="page" to="353">353</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">FD82B6B0535553A995DE84CEDF512FDC6E98A34F</idno>
<idno type="DOI">10.1002/mds.870060415</idno>
<idno type="ArticleID">MDS870060415</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Ballistic movement overflow myoclonus</term>
<term>Biperiden (therapeutic use)</term>
<term>Case study</term>
<term>Central nervous system</term>
<term>Cholinergic Fibers (drug effects)</term>
<term>Cholinergic Fibers (physiology)</term>
<term>Cholinergic disturbance</term>
<term>Computerized axial tomography</term>
<term>Drug response</term>
<term>Electrodiagnosis</term>
<term>Electromyography</term>
<term>Electromyography (drug effects)</term>
<term>Exploration</term>
<term>Hemibalismus</term>
<term>Humans</term>
<term>Infusions, Intravenous</term>
<term>Male</term>
<term>Muscle Contraction (drug effects)</term>
<term>Muscle Contraction (physiology)</term>
<term>Muscles (innervation)</term>
<term>Myoclonus</term>
<term>Myoclonus (drug therapy)</term>
<term>Myoclonus (physiopathology)</term>
<term>Neurologic Examination</term>
<term>Radiodiagnosis</term>
<term>Receptors, Cholinergic (drug effects)</term>
<term>Receptors, Cholinergic (physiology)</term>
<term>Treatment efficiency</term>
<term>Young adult</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>Receptors, Cholinergic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Receptors, Cholinergic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Biperiden</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Cholinergic Fibers</term>
<term>Electromyography</term>
<term>Muscle Contraction</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Myoclonus</term>
</keywords>
<keywords scheme="MESH" qualifier="innervation" xml:lang="en"><term>Muscles</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Cholinergic Fibers</term>
<term>Muscle Contraction</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Myoclonus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Humans</term>
<term>Infusions, Intravenous</term>
<term>Male</term>
<term>Neurologic Examination</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Adulte jeune</term>
<term>Efficacité traitement</term>
<term>Electrodiagnostic</term>
<term>Electromyographie</term>
<term>Etude cas</term>
<term>Exploration</term>
<term>Hémiballisme</term>
<term>Myoclonie</term>
<term>Radiodiagnostic</term>
<term>Système nerveux central</term>
<term>Tomodensitométrie</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A 27‐year‐old man presented with a sporadic, nonprogressive, right‐sided, segmental movement disorder that had started at the age of 2 years. Ballistic movement overflow myoclonus was diagnosed clinically and by surface electromyography. Special investigations did not detect anything except atrophy of the left temporal lobe on CT scan. The movement intensity was attenuated by alcohol but was minimally affected by high doses of oral propranolol (320 mg daily), clonazepam (36 mg daily), or trihexyphenidyl (32 mg daily). High‐dose intravenous biperidine (10 mg) resulted in dramatic improvement, but with unacceptable side effects. The possible role of a cholinergic disturbance in generating myoclonus is discussed.</div>
</front>
</TEI>
<affiliations><list><country><li>Afrique du Sud</li>
</country>
</list>
<tree><country name="Afrique du Sud"><noRegion><name sortKey="Stubgen, J" sort="Stubgen, J" uniqKey="Stubgen J" first="J." last="Stübgen">J. Stübgen</name>
</noRegion>
<name sortKey="Lotz" sort="Lotz" uniqKey="Lotz" last="Lotz">Lotz</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006125 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006125 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:FD82B6B0535553A995DE84CEDF512FDC6E98A34F
   |texte=   Segmental ballistic movement overflow myoclonus: A clinical, electromyographic, and pharmacologic evaluation
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Segmental ballistic movement overflow myoclonus: A clinical, electromyographic, and pharmacologic evaluation

Segmental ballistic movement overflow myoclonus: A clinical, electromyographic, and pharmacologic evaluation

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.